A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight
Status:
COMPLETED
Trial end date:
2024-08-27
Target enrollment:
Participant gender:
Summary
The main objective of the study is to assess the pharmacokinetics (PK) of Maridebart Cafraglutide after a single subcutaneous (SC) administration in overweight or obese Chinese participants.